Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Open Label Study of H.P. Acthar Gel Injection in Patients With Active Non-Infectious Uveitis With Associated Glaucoma Thus High Frequency Regional Corticosteroid and Oral Corticosteroids Cause Intolerable Side-Effects

NCT02764697 is registered in ClinicalTrials.gov with Tampa Bay Uveitis Center, LLC as lead sponsor.

NCT NCT02764697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02764697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Open Label Study of H.P. Acthar Gel Injection in Patients With Active Non-Infectious Uveitis With Associated Glaucoma Thus High Frequency Regional Corticosteroid and Oral Corticosteroids Cause Intolerable Side-Effects
Lead sponsor
Tampa Bay Uveitis Center, LLC
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2016
Completion date
December 20, 2016
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior uveitis, clinically significant macular edema, intermediate uveitis, posterior uveitis, scleritis, uveitis